In the preceding three months, 16 analysts have released ratings for Paycor HCM PYCR, presenting a wide array of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 2 | 9 | 1 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 6 | 1 | 0 |
| 2M Ago | 2 | 2 | 1 | 0 | 0 |
| 3M Ago | 2 | 0 | 1 | 0 | 0 |
Analysts have recently evaluated Paycor HCM and provided 12-month price targets. The average target is $23.09, accompanied by a high estimate of $30.00 and a low estimate of $20.00. Marking an increase of 8.25%, the current average surpasses the previous average price target of $21.33.
Breaking Down Analyst Ratings: A Detailed Examination
A clear picture of Paycor HCM's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Mark Marcon | Baird | Lowers | Neutral | $22.50 | $28.00 |
| Mark Murphy | JP Morgan | Raises | Underweight | $22.50 | $21.00 |
| Steven Enders | Citigroup | Raises | Neutral | $22.50 | $21.00 |
| Terry Tillman | Truist Securities | Raises | Hold | $22.50 | $20.00 |
| Charles Nabhan | Stephens & Co. | Raises | Equal-Weight | $22.50 | $20.00 |
| Patrick Walravens | JMP Securities | Announces | Market Perform | $30.00 | - |
| Siti Panigrahi | Mizuho | Raises | Neutral | $22.50 | $20.00 |
| Daniel Jester | BMO Capital | Lowers | Market Perform | $22.50 | $24.00 |
| Patrick Walravens | JMP Securities | Maintains | Market Outperform | $30.00 | $30.00 |
| Scott Berg | Needham | Maintains | Buy | $20.00 | $20.00 |
| Brad Reback | Stifel | Raises | Buy | $25.00 | $22.00 |
| Siti Panigrahi | Mizuho | Raises | Neutral | $20.00 | $18.00 |
| Daniel Jester | BMO Capital | Raises | Outperform | $24.00 | $19.00 |
| Bryan Bergin | TD Cowen | Raises | Buy | $22.00 | $18.00 |
| Gabriela Borges | Goldman Sachs | Raises | Neutral | $21.00 | $19.00 |
| Scott Berg | Needham | Maintains | Buy | $20.00 | $20.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Paycor HCM. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Paycor HCM compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Paycor HCM's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Paycor HCM's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Paycor HCM analyst ratings.
All You Need to Know About Paycor HCM
Paycor HCM provides payroll and human capital management solutions to small and midsize clients in the United States via a software-as-a-service model. Alongside core payroll functionality, the firm's platform offers a suite of HCM solutions including talent management and time and attendance software, third-party integration capabilities, and industry-specific configurations. The firm targets customers with 10-1,000 employees and had over 30,500 customers as of June 2024.
Key Indicators: Paycor HCM's Financial Health
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Paycor HCM showcased positive performance, achieving a revenue growth rate of 16.64% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Paycor HCM's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -4.35%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Paycor HCM's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -0.56%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Paycor HCM's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.29%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.
How Are Analyst Ratings Determined?
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
